Literature DB >> 28987942

miR-205 regulation of ICT1 has an oncogenic potential via promoting the migration and invasion of gastric cancer cells.

Youmao Tao1, Yan Song1, Tao Han2, Changjing Wang1, Tongquan Zhao1, Ye Gu3.   

Abstract

Immature colon carcinoma transcript-1 (ICT1) is a newly identified oncogene, which regulates mobility, apoptosis, cell cycle progression and proliferation of cancer cells. Nevertheless, the role of ICT1 and its clinical significance in gastric cancer (GC) is largely uncovered. Here, we found that ICT1 displayed higher expression in GC tissues compared to corresponding tumor-adjacent tissues. Further investigation confirmed ICT1 overexpression in GC cell lines. Clinical data disclosed that high ICT1 expression correlated with distant metastasis and advanced tumor-node-metastasis (TNM) stage. The Cancer Genome Atlas (TCGA) data further demonstrated that GC tissues with metastasis showed a significant higher level of ICT1 compared to those without metastasis. Furthermore, ICT1 overexpression notably predicted poor prognosis of GC patients. Functionally, we demonstrated that ICT1 knockdown suppressed invasion and migration of MGC-803 and BGC-823 cells in vitro. ICT1 overexpression promoted the mobility of SGC-7901 cells. Mechanistically, microRNA-205 (miR-205) was recognized as a direct down-regulator and inversely modulated ICT1 abundance in GC cells. miR-205 expression was down-regulated and negatively associated with ICT1 level in GC tissues. Underexpression of miR-205 indicated an obvious shorter survival of GC patients. miR-205 overexpression inhibited migration and invasion of MGC-803 cells, while these inhibitory effects were reversed by ICT1 restoration. Taken together, we have the earliest evidence that miR-205 regulation of ICT1 functions as an oncogene and prognostic biomarker in GC.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Clinical significance; GC; ICT1; Tumor metastasis; miR-205

Mesh:

Substances:

Year:  2017        PMID: 28987942     DOI: 10.1016/j.biopha.2017.09.147

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  [miR-203 inhibits lung cancer cell metastasis by targeting fatty acid binding protein 4].

Authors:  Ji-Chao Chen; Xu Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-05-20

2.  Advantages of Restoring miR-205-3p Expression for Better Prognosis of Gastric Cancer via Prevention of Epithelial-mesenchymal Transition.

Authors:  Zhen Zhang; Xujun He; Ji Xu; Genhua Zhang; Yue Yang; Jie Ma; Yuanshui Sun; Haibin Ni; Fengyong Wang
Journal:  J Gastric Cancer       Date:  2020-05-18       Impact factor: 3.720

3.  MicroRNA-1296 Facilitates Proliferation, Migration And Invasion Of Colorectal Cancer Cells By Targeting SFPQ.

Authors:  Youmao Tao; Chong Ma; Qihao Fan; Yannan Wang; Tao Han; Caixia Sun
Journal:  J Cancer       Date:  2018-06-06       Impact factor: 4.207

4.  Essential Oil from Pinus Koraiensis Pinecones Inhibits Gastric Cancer Cells via the HIPPO/YAP Signaling Pathway.

Authors:  Yandong Zhang; Chao Xin; Junqiang Qiu; Zhenyu Wang
Journal:  Molecules       Date:  2019-10-25       Impact factor: 4.411

5.  ICT1 Promotes Osteosarcoma Cell Proliferation and Inhibits Apoptosis via STAT3/BCL-2 Pathway.

Authors:  Xiaohui Pan; Jingxue Tan; Xiaokun Weng; Rui Du; Yuqing Jiang; Yiping Weng; Dong Zhou; Yifei Shen
Journal:  Biomed Res Int       Date:  2021-01-22       Impact factor: 3.411

Review 6.  Functional Diversity of Mitochondrial Peptidyl-tRNA Hydrolase ICT1 in Human Cells.

Authors:  I V Chicherin; S V Dukhalin; R A Khannanov; M V Baleva; S A Levitskii; M V Patrushev; P V Sergiev; P Kamenski
Journal:  Front Mol Biosci       Date:  2021-07-16

7.  Downregulation of miR-205 contributes to epithelial-mesenchymal transition and invasion in triple-negative breast cancer by targeting HMGB1-RAGE signaling pathway.

Authors:  Ling Wang; Fu-Biao Kang; Juan Wang; Chao Yang; Dong-Wei He
Journal:  Anticancer Drugs       Date:  2019-03       Impact factor: 2.248

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.